Bone News and Research

RSS

Harnessing body's own natural killer cells to battle cancer in children

Work underway at St. Jude Children's Research Hospital seeks to harnesses the body's own immune cells known as natural killer, or NK, cells to help children battle cancer. NK cells are the immune system's warriors. The cells circulate widely in the body, armed with proteins, called enzymes, capable of delivering a deadly one-two punch to viruses and cancer cells.

3 Apr 2010

Nephros' 2009 product revenues up 81%

Nephros, Inc. announced today financial results for the twelve month period ended December 31, 2009.

3 Apr 2010

Beike Biotechnology awarded ISO9001 certification for implementation of comprehensive QMS

Beike Biotechnology Co. Ltd., one of the world's leading biotechnology companies focusing on adult stem cell therapies, has been awarded ISO9001 certification by the International Organization for Standardization ("ISO"). This internationally recognized designation signifies Beike has established a Quality Management System (QMS) that complies with ISO9001 standards.

3 Apr 2010

Multnomah Court Judge denies I-Flow's request for new trial

Judge Youlee You today denied a request by defendant I-Flow for a new trial in Multnomah County Circuit Court. The ruling follows the January 22 jury verdict against the pain pump manufacturer. Jurors awarded $5.475 million for the destruction of Portland-area resident Matthew Beale's right shoulder. They found the damage was caused by the On-Q Painbuster infusion pain pump, manufactured and marketed by I-Flow.

2 Apr 2010

ASA classification can help identify impact of hip surgery in high-risk patients

Hip fractures are the second leading cause of hospitalization of elderly patients. In many cases, a hip fracture is the first step in a complete decline in the patient's health, setting off a long list of potential complications.

2 Apr 2010

Capital Region Orthopaedics to implement Allscripts EHR and Practice Management solution

Allscripts today announced that Capital Region Orthopaedics has selected the Allscripts Electronic Health Record (EHR) and Practice Management solution to automate and connect 27 physicians in six locations across the Albany area.

2 Apr 2010

Sunshine vitamin cures common health problems

What do obesity, heart disease, depression, diabetes, and fibromyalgia have in common? The answer is vitamin D deficiency. More than 200 million Americans lack this essential vitamin and as a result suffer from a host of daily annoyances, chronic conditions, and even life-threatening illnesses.

2 Apr 2010

Study finds potential role of NGF in islet transplantation

Islet transplantation is a promising treatment for type 1 diabetes mellitus. The promotion of angiogenesis is an important endeavor to prevent islet graft failure. Endothelial precursor cells (EPCs), a heterogeneous group originating in the hematopoietic compartment of bone marrow, have an important role in the angiogenesis of adult tissues.

2 Apr 2010

UK NICE recommends Eli Lilly's ALIMTA as maintenance therapy for nonsquamous NSCLC

Eli Lilly and Company announced today that its chemotherapy ALIMTA® (pemetrexed for injection) received a positive "Final Appraisal Determination" from the United Kingdom's National Institute for Health and Clinical Excellence (NICE).

2 Apr 2010

Leg length inequality linked to osteoarthritis: Study

A new study shows that arthritis in the knee is linked to the common trait of having one leg that is longer than the other. Whether or not leg length differential is a direct cause of osteoarthritis is not clear, but the findings may allow people to take preventive measures before the onset of the chronic and painful condition.

1 Apr 2010

Substances from vegetable lamb plant show promise for treatment of osteoporosis

The "vegetable lamb" plant - once believed to bear fruit that ripened into a living baby sheep - produces substances that show promise in laboratory experiments as new treatments for osteoporosis, the bone-thinning disease. That's the conclusion of a new study in ACS' monthly Journal of Natural Products.

1 Apr 2010

Genta commences Phase 2b trial of tesetaxel in patients with advanced gastric cancer

Genta Incorporated today announced that the Company has initiated a confirmatory Phase 2b trial of tesetaxel in patients with advanced gastric cancer. Tesetaxel is the Company's newest clinical-stage small molecule. As a late Phase 2 oncology product, tesetaxel is the leading oral taxane currently in clinical development.

31 Mar 2010

SANUWAVE Health reports net loss of $2.7M for three months ended December 31, 2009

SANUWAVE Health, Inc., an emerging medical technology company focused on regenerative medicine, reports its financial results for the fourth quarter and full year ended December 31, 2009, and on its progress for the year.

31 Mar 2010

In-depth practitioner training and experience critical for successful dental implant procedure

Burgeoning consumer demand for dental implants has prompted dentists nationwide to add implants to their practices, and some have mounted aggressive advertising campaigns to promote implants to consumers. But how can patients objectively evaluate the qualifications of a dentist to perform implant surgery?

31 Mar 2010

$Notch pathway could aid treatment of osteoporosis, fractures and arthritis$

Notch pathway could aid treatment of osteoporosis, fractures and arthritis

Scientists seeking new ways to fight maladies ranging from arthritis and osteoporosis to broken bones that won't heal have cleared a formidable hurdle, pinpointing and controlling a key molecular player to keep stem cells in a sort of extended infancy.

31 Mar 2010

Dr. Ingmar Bruns selected as seventh recipient of EHA-ASH Research Exchange Award

The European Hematology Association and the American Society of Hematology have selected Ingmar Bruns, MD, as the seventh recipient of the EHA-ASH Research Exchange Award, which serves to strengthen ties between North American and European scientific communities.

31 Mar 2010

YM BioSciences receives approval to expand enrolment in Phase I/II clinical trial of CYT387

YM BioSciences Inc., announced that it has received ethics board approval to expand enrolment in its Phase I/II clinical trial of CYT387 at Mayo Clinic in patients with myelofibrosis, a chronic debilitating condition, where patient's bone marrow is replaced by scar tissue.

31 Mar 2010

SpineAlign Medical announces VerteLift as new name for vertebral implant system

SpineAlign Medical Inc. announced today that it has chosen a new trademark name, VerteLift, for its vertebral implant system. Formerly called the SpineAlign System, the name reflects the advantages of the product that the Company will leverage going forward.

30 Mar 2010

Researchers find Dpp protein causes metastatic tumour migration

One of the most intriguing questions in cancer research is what causes metastatic tumour migration, why some tumour cells manage to migrate to other parts of the body but others cells don't. International investigation conducted by Enrique Mart-n Blanco, CSIC researcher at the Institute of Biology of Barcelona, located in the Barcelona Science Park, reveals that cells make use of a natural mechanism for this.

30 Mar 2010

Plaques in blood vessels may break by overproducing protein-digesting enzymes

University of Washington (UW) researchers have gathered evidence that dangerous plaques in blood vessels can rupture by overproducing protein-digesting enzymes. Plaques are fat-laden rough spots in the otherwise smooth walls of arteries. When a plaque ruptures, blood accumulates inside of it, a process known as plaque hemorrhage. The plaque enlarges and artery-blocking clots can form. If the flow of oxygen-rich blood is restricted, a heart attack, stroke, or damage to other organs can occur.

30 Mar 2010

Bone News and Research

Harnessing body's own natural killer cells to battle cancer in children

Nephros' 2009 product revenues up 81%

Beike Biotechnology awarded ISO9001 certification for implementation of comprehensive QMS

Multnomah Court Judge denies I-Flow's request for new trial

ASA classification can help identify impact of hip surgery in high-risk patients

Capital Region Orthopaedics to implement Allscripts EHR and Practice Management solution

Sunshine vitamin cures common health problems

Study finds potential role of NGF in islet transplantation

UK NICE recommends Eli Lilly's ALIMTA as maintenance therapy for nonsquamous NSCLC

Leg length inequality linked to osteoarthritis: Study

Substances from vegetable lamb plant show promise for treatment of osteoporosis

Genta commences Phase 2b trial of tesetaxel in patients with advanced gastric cancer

SANUWAVE Health reports net loss of $2.7M for three months ended December 31, 2009

In-depth practitioner training and experience critical for successful dental implant procedure

Notch pathway could aid treatment of osteoporosis, fractures and arthritis

Dr. Ingmar Bruns selected as seventh recipient of EHA-ASH Research Exchange Award

YM BioSciences receives approval to expand enrolment in Phase I/II clinical trial of CYT387

SpineAlign Medical announces VerteLift as new name for vertebral implant system

Researchers find Dpp protein causes metastatic tumour migration

Plaques in blood vessels may break by overproducing protein-digesting enzymes

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News